Valneva SE Revenue

Valneva SE had revenue of 30.90M EUR in the quarter ending March 31, 2026, a decrease of -37.23%. This brings the company's revenue in the last twelve months to 156.33M, down -15.98% year-over-year. In the year 2025, Valneva SE had annual revenue of 174.66M with 3.00% growth.

Revenue (ttm)

156.33M

Revenue Growth

-15.98%

P/S Ratio

2.75

Revenue / Employee

231.95K

Employees

674

Market Cap

430.50M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	174.66M	5.08M	3.00%
Dec 31, 2024	169.58M	15.87M	10.32%
Dec 31, 2023	153.71M	-207.59M	-57.46%
Dec 31, 2022	361.30M	13.22M	3.80%
Dec 31, 2021	348.09M	237.76M	215.52%
Dec 31, 2020	110.32M	-15.88M	-12.58%
Dec 31, 2019	126.20M	13.16M	11.64%
Dec 31, 2018	113.04M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Genfit	70.85M
Cellectis	65.14M
Nanobiotix	32.59M
MedinCell	24.28M
Innate Pharma	9.01M
Transgene	7.21M
Inventiva	6.76M
Sensorion	5.81M

Revenue Rankings

Valneva SE News

18 days ago - Valneva Announces Successful Outcome of its Annual General Meeting - GlobeNewsWire
5 weeks ago - Valneva SE Registration statement: Registration filing - Filings
5 weeks ago - Valneva Announces Availability of Documentation for its Annual General Meeting - GlobeNewsWire
5 weeks ago - Valneva SE Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
5 weeks ago - Valneva SE Slides: Investor presentation - Filings
6 weeks ago - Valneva to Participate at U.S. and European Investor Conferences in June - GlobeNewsWire
2 months ago - Valneva SE Earnings Call Transcript: Q1 2026 - Transcripts
2 months ago - Valneva SE Earnings release: Q1 2026 - Filings

More News